Location

Rochester, Minnesota

Contact

AcostaCardenas.Andres@mayo.edu Clinical Profile

SUMMARY

Andres J. Acosta Cardenas, M.D., Ph.D., focuses his research on gastrointestinal physiology to understand the complexity of food intake regulation and obesity. Obesity is a primary cause of type 2 diabetes, fatty liver disease, cardiovascular disease and cancer. Dr. Acosta's laboratory utilizes a combination of genetics, physiology, pharmacology, proteomics, metabolomics, and gastrointestinal and brain imaging to understand food intake regulation and to modulate them for the treatment of obesity. In collaboration with his mentor, Michael Camilleri, M.D., Dr. Acosta is using cutting-edge techniques to understand the pharmacotherapy and pharmacogenomics of obesity.

Dr. Acosta's main focus is on the mechanisms and regulation of appetite, satiation and satiety, including the role of gastric function, gastrointestinal hormones, taste preferences, bile acids, and enterohepatic regulation and gut energy utilization. Additionally, Dr. Acosta studies the effect of genetics, pharmacology and endoscopic devices on food intake regulation.

Focus areas

  • Food intake regulation. Dr. Acosta seeks to understand the regulation of satiation and the complex interaction among the gut, liver and brain.
  • Individualized obesity therapy. Dr. Acosta's recent work focuses on understanding gastrointestinal traits associated with obesity, weight gain and weight loss. These traits are used to predict obesity therapy outcomes with the intention of individualizing treatment. Dr. Acosta applies individual differences in quantitative studies of gastrointestinal functions, behavioral and psychological traits in overweight and obesity to propose individualizing or personalizing therapy directed at specific traits.
  • Obesity pharmacotherapy. Dr. Acosta's laboratory focuses on identifying novel therapeutic targets utilizing cutting-edge techniques in the areas of molecular biology, biochemistry, genetics, neuroimaging and pharmacology.
  • Genetics and obesity therapy. The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a major focus of Dr. Acosta's lab.

Significance to patient care

Dr. Acosta's goal is to treat and ultimately cure obesity, which he considers this century's health epidemic. Dr. Acosta's work on individualized obesity therapy aims to identify the right therapy for the right patient, minimizing side effects.

Eventually, Dr. Acosta hopes to understand the mechanisms behind food intake regulation and weight to develop novel techniques and therapies. In the meantime, Dr. Acosta shares his knowledge and research experience with patients with obesity in Mayo Clinic's weight loss clinic.

Professional highlights

  • AGA/AGA-GRG travel award for Digestive Diseases Week, American Gastroenterology Association (AGA), 2015
  • Young Investigator Forum award, American Neurogastroenterology and Motility Society, 2014
  • Chairman, Leighton E. Cluff award, University of Florida Department of Medicine Residency Program, 2012
  • Excellence in teaching award, University of Florida Department of Medicine, 2012
  • Medical Guild award, University of Florida College of Medicine, 2009

PUBLICATIONS

See my publications

PROFESSIONAL DETAILS

Primary Appointment

  1. Senior Associate Consultant, Division of Gastroenterology and Hepatology, Department of Internal Medicine

Academic Rank

  1. Assistant Professor of Medicine

EDUCATION

  1. Postdoctoral Research Fellowship - NIH T32 program Post Doctoral Clinical - Research Fellowship Gastroenterology and Hepatology Mayo Clinic
  2. Clinical Fellowship - Gastroenterology and Hepatology Mayo Clinic
  3. Certificate - 14 credit hours in statistics, epidemiology and clinical research Mayo Clinic Department of Development and the Mayo Clinic Center for Translational Science Activities (CTSA)
  4. Residency - Internal Medicine University of Florida, Shands/UF Hospital
  5. Internship - Internal Medicine University of Florida, Shands/UF Hopsital
  6. Ph.D. - Doctorate in Philosophy - Physiology and Pharmacology University of Florida, College of Medicine
  7. MD - Magna Cum Lauden Universidad San Francisco de Quito
  8. BS - Bachelor in Health Science - Magna Cum Lauden Universidad San Francisco de Quito
.
BIO-20189108

Mayo Clinic Footer